With the discipline of precision medicine as our foundation, Precision Medicine Group leverages specialized expertise to move science closer to health.
We collaborate from home offices and high-tech facilities to help life science companies move discoveries from molecule to medicine cabinets. These are times of transformation. How might you break through? Life At Precision Why work with us? The reasons are many. ...
biospecimens bridge the gap between a patient’s biological characteristics and the creation of individualised treatment plans in the field of precision medicine. In order to take benefit of more cost-effective procedures and get over the current capacity limits, the pharmaceutical sector is increasingl...
Read how precision medicine personalizes medical treatments for individual patients, accounting for genetic, environmental and behavioral information.
the misalignments that exist between a diverse group of stakeholders.Inside Precision Medicineembraces the challenge to think differently and to play its part in effecting real progress and change, focusing on scaling and streamlining the precision medicine continuum for the benefit of patients in need...
Precision MedicineP1846IMPROVING TURNAROUND TIME FOR ANTIPSYCHOTIC BLOOD LEVELS WITH THE BECKMAN COULTER DXC 700 AUCHEMISTRY ANALYSERJ. Fritz 1, D. Kozo 1, J. Wisnoski 1, M.R. Hilaire 11Saladax Biomedical Inc., Bethlehem, PA, USABACKGROUND-AIMAdherence to antipsychotic medication is critical fo...
(Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands) are the key players in the precision medicine software market. Syapse is one of the leading players ...
Precision for Medicine, the first global biomarker-driven clinical research and development organization, today announced that it has acquired...
medicine. Many claim that medicine has always been personalized, as physicians treat individuals. Thus, the terminology “precision medicine” arose to describe this approach. In contrast to a more traditional approach in which strategies are developed for a group or cohort of patients with a ...
Arkady Gusev, PhD, Head, Lab Excellence & Operations in Biomarker Development, Novartis Institutes for BioMedical Research, Inc. Exploratory biomarkers enable clinical decision making and often paves the way for precision medicine approaches in drug development. This presentation will focus on systematic...